We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 40
Most popular |Most recent


FDA to Consider Approval of Botanical (not synthetic) CBD Drug

USA - April 17 2018 On Thursday April 18, 2018, at 8:00AM-12:30PM EST, an FDA advisory panel will consider whether to recommend or not recommend approval of GW...


Pennsylvania Medical Marijuana Program to Begin Phase II Permitting

USA - March 22 2018 On April 5, 2018, Phase 2 of the PA Department of Health’s permitting for commercial medical marijuana cultivation and dispensary operations will...


Cannabis Trading on Major U.S. Stock Exchange

USA - February 28 2018 Another breakthrough for the cannabis space occurred on Tuesday, February 27, 2018, when Toronto-based Cronos Group Inc. began trading on the Nasdaq...


Contingency Fees and Commercial Litigation Hit the Cannabis Space

USA - February 2 2018 As the values of transactions in the cannabis industry grow, commercial litigation is certain to follow. One reason for this is that lawyers may be...


“Cannabis 101” Webinar Replay Available

USA - January 31 2018 A video replay of the webinar Cannabis 101: Update on the Federal Enforcement & State Regulatory Environment is available to view....

David N. Feldman, Paul P. Josephson, Nicholas J. Ferraro, Joseph J. Machi, Justin A. Santarosa, Patricia H. Heer, Alexandra Slavet, Jennifer Briggs Fisher, Neville M. Bilimoria, Gretchen L. Temeles, Ph.D., Christiane Schuman Campbell.